Title Category Credit Event date Cost
Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team
  • Disease Management
  • Oncology
  • Transplantation
  • ABTC
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • APA
  • ASWB
  • Attendance
  • CCMC - General
  • CMCN
04/11/2019 $310.00 Exciting, new, relevant topics!Why should you attend? Whether you are just launching your career in the field of transplantation or oncology or you have been managing transplant or cancer patients for years, this accredited educational activity is designed to deliver the information you need for the care and management of these patient populations.
At-Risk Populations and Evidence-Based Guidelines for Acute Stroke Management
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 This activity consists of recorded presentations from the "12th Annual Medical Director/Physician Leadership Forum" held in Las Vegas, NV on JUNE 13, 2018.Every year 795,000 individuals experience acute stroke, making it the fifth leading cause of death in the U.S. Stroke poses a significant economic burden that is expected to more than double by 2035.
Chronic Obstructive Pulmonary Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 This activity consists of recorded presentations from the "12th Annual Medical Director/Physician Leadership Forum" held in Las Vegas, NV on JUNE 13, 2018.
Precision Medicine: The Customization of Health Care
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 This activity consists of recorded presentations from the "12th Annual Medical Director/Physician Leadership Forum" held in Las Vegas, NV on JUNE 13, 2018.
Chronic Kidney Disease: Early and Effective Intervention and Evidence-based Guidelines for Optimal Management
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Chronic kidney disease (CKD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted. It is responsible for premature death and demands a high economic price from both the private and public sectors. The prevalence of CKD is increasing, and more than 50 percent of adults 30–64 years old are projected to develop CKD over their lifetimes.
Chronic Pain Is a Disease, Not a Symptom of Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 When pain becomes chronic, it is no longer merely a symptom, but a disease in itself. According to the National Health Interview Survey, an estimated 25.3 million adults in the United States suffer from chronic pain. This activity will focus on what is new in the management of chronic pain and in what ways this field is evolving. The importance of interprofessional strategies to integrate pharmaceutical and nonpharmaceutical treatment options for chronic pain will be addressed, as well as the importance of improving communication with patients about chronic pain diagnosis and treatment.
Current and Future Applications of Gene Therapy for Various Disease States
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Gene therapy has been investigated as a potential intervention in a number of diseases and/or disorders, including chronic neuropathic pain, melanoma, cardiovascular disease and cancer. This activity will review the latest evidence-based practice guidelines surrounding gene therapies, as well as available safety and efficacy data surrounding its use in a variety of disease states.Learning ObjectivesAt the end of this educational activity, participants should be able to:
Medical Advances and Optimal Treatment Approaches for Inflammatory Bowel Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 The Centers for Disease Control (CDC) estimate that 1 to 1.3 million people suffer from inflammatory bowel disease (IBD) in the United States. These patients often require long-term management involving steroids, maintenance therapy with immunomodulators and biologicals, and acute interventions. During this activity, factors affecting the risk and course of IBD and the most updated protocols and guidelines for diagnosing and treating IBD will be discussed. New therapies targeting the immune process that are revolutionizing the treatment of IBD will also be presented.
Preventive Cardiovascular Care: What is New
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Accumulating evidence has revealed that intestinal microbiota play an important role in human health and disease, including cardiovascular diseases. This activity will discuss the roles of gut microbiota and focus on gut microbes as a factor and therapeutic target in cardiovascular disease. In addition, the latest guidelines for prevention and treatment of co-morbid conditions associated with cardiovascular disease will be reviewed.Learning ObjectivesAt the end of this educational activity, participants should be able to:
Cardiovascular Disease: Guidelines and Challenges in Patient Management
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 In 2013, the American College of Cardiology (ACC) and the American Heart Association (AHA), developed new guidelines for the treatment of blood cholesterol and risk assessment of atherosclerotic cardiovascular disease (ASCVD). The new guidelines recommend the use of statin therapy as the medication of choice in ASCVD risk reduction. This was a major shift from the old approach, creating controversies and a state of confusion.

Pages